Bayer

Germanybayer.com

Its roles Owner Operator Offtaker

projects tracked
23
active
6
countries
5
plants
11

Bayer AG is a German multinational life science and chemical company headquartered in Leverkusen, founded in 1863. Its core businesses span Pharmaceuticals, Consumer Health, and Crop Science, with activities ranging from discovery and development to large‑scale manufacturing of active pharmaceutical ingredients (such as acetylsalicylic acid), over‑the‑counter health products, seeds, and crop protection chemicals. The company operates a global network of research, production, and distribution sites, including regional entities such as Bayer Taiwan Co., Ltd.

Read more

For the chemical industry, Bayer is notable for its pharmaceutical and agrochemical process chemistry and legacy in materials science; its materials business was separated as Covestro in 2015. Bayer is pursuing energy transition measures in its operations, including long‑term power and heat purchase agreements to support electrification and decarbonization at manufacturing sites, such as the acetylsalicylic acid plant in La Felguera, Spain.

Also known as Bayer Group, Bayer AG Taiwan Branch, Bayer Taiwan Co., Ltd., and Bayer Taiwan.

Projects Bayer is involved in

chemXplore tracks 23 projects involving Bayer, of which 6 are active.

  1. 2 projects Announced / Concept
  2. none FEED / Pre-FID
  3. none FID / Sanctioned
  4. 3 projects Under Construction
  5. 1 project Commissioning & Start-up

Besides these 6, the record holds 16 completed projects and 1 cancelled.

Active projects

Closest to start-up first.

1 more active project and the 17 that are completed, on hold or cancelled are in the record. See all 23 in chemXplore →

What moved recently

  • 2 October 2026 Bayer New Albany pharmaceutical manufacturing campus · Announced / Concept · United States
  • May 2026 Bayer Orizaba API plant modernisation · Under Construction · Mexico

What its projects make

Bayer in chemical industry news

5 November 2026
Iberdrola tests 100% renewable-steam electrification at Bayer's Asturias plant

Uses molten-salt thermal storage, a 15 MW PPA and 2.5 MW PV; avoids ~6,500 tCO2/yr; >€18m investment and Spain's first large-scale heat-electrification project with storage.

4 November 2026
Bayer’s sevabertinib approved in China as first‑line therapy for HER2‑mutant NSCLC

China’s NMPA cleared an oral, reversible HER2‑targeting TKI for first‑line use in unresectable or metastatic HER2‑mutant NSCLC based on Phase I/II ORR and DOR data.

3 November 2026
Bayer lifts full‑year outlook after Q3 sales and EBITDA gains

Pharma growth driven by Nubeqa and Kerendia; asundexian cleared in China; Group raises Pharma margin and Group EBITDA-before-special-items guidance, improves cash and debt outlook.

30 October 2026
Monsanto wins unanimous defense verdict in first post‑Durnell Roundup trial

Jury cleared Monsanto on design‑defect, fraud and negligence claims in a three‑plaintiff case — the first Roundup trial after the Supreme Court’s June 2026 Durnell ruling.

26 October 2026
Bayer’s asundexian (Sunharbo) approved in China to reduce recurrent ischemic stroke risk

First Factor XIa inhibitor worldwide approved to lower recurrent ischemic stroke risk after non‑cardioembolic stroke or high‑risk TIA in adults.

24 October 2026
Bayer: Darolutamide with ADT and RT Cuts Metastasis-or-Death Risk 58% in High‑Risk Prostate Cancer

Interim Phase III DASL-HiCaP results show darolutamide added to ADT and radiation significantly improves metastasis-free survival versus placebo in high‑risk patients.

15 October 2026
Vividion Therapeutics starts Phase II of WRN inhibitor VVD-214 in first-line MSI‑high/dMMR colorectal cancer

Randomized Phase II will test VVD-214 plus pembrolizumab versus pembrolizumab alone as first‑line treatment for advanced MSI‑high/dMMR colorectal cancer, enrolling ~140 patients.

8 October 2026
Bayer’s finerenone sNDA accepted by FDA for CKD without diabetes

FDA acceptance of finerenone sNDA for adults with CKD without diabetes follows Phase III FIND‑CKD showing slower eGFR decline and reduced cardio‑kidney events versus placebo.

Where its projects are

active all projects

chemXplore Cluster Watch · updated daily
The 16 chemical clusters of Northwest Europe, read as one system
Hydrogen CO2 Oil, gas and chemicals Heat and power
Open the map →

Chemical parks it is at

Partners on its projects

The 6 sharing the most projects, of 7.